Abstract
Purpose: A simple stability-indicating RP-HPLC assay method was developed and validated for quantitative determination of Chloramphenicol, Dexamethasone Sodium Phosphate and Tetrahydrozoline Hydrochloride in ophthalmic solution in the presence of 2- amino-1-(4-nitrophenyl)propane-1,3-diol, a degradation product of Chloramphenicol, and Dexamethasone, a degradation product of Dexamethasone Sodium Phosphate. Methods: Effective chromatographic separation was achieved using C18 column (250 mm, 4.6 mm i.d., 5 μm) with isocratic mobile phase consisting of acetonitrile - phosphate buffer (pH 4.0; 0.05 M) (30:70, v/v) at a flow rate of 1 mL/minute. The column temperature was maintained at 40°C and the detection wavelength was 230 nm. Results: The proposed HPLC procedure was statistically validated according to the ICH guideline, and was proved to be stability-indicating by resolution of the APIs from their forced degradation products. Conclusion: The developed method is suitable for the routine analysis as well as stability studies.
Author supplied keywords
Cite
CITATION STYLE
AlAani, H., & Alnukkary, Y. (2016). Stability-indicating HPLC method for simultaneous determination of chloramphenicol, dexamethasone sodium phosphate and tetrahydrozoline hydrochloride in ophthalmic solution. Advanced Pharmaceutical Bulletin, 6(1), 137–141. https://doi.org/10.15171/apb.2016.020
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.